Last reviewed 2026-04-20 · How we verify

Oral [14C]PF-07220060 (oral-14c-pf-07220060)

Pfizer Inc. · Phase 1 active Quality 0/100

Oral [14C]PF-07220060 (generic name: oral-14c-pf-07220060) is a drug developed by Pfizer Inc.. It is currently in Phase 1 development.

At a glance

Generic name	oral-14c-pf-07220060
Sponsor	Pfizer Inc.
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oral [14C]PF-07220060 CI brief — competitive landscape report
Oral [14C]PF-07220060 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI

Frequently asked questions about Oral [14C]PF-07220060

What is Oral [14C]PF-07220060?

Oral [14C]PF-07220060 (oral-14c-pf-07220060) is a pharmaceutical drug developed by Pfizer Inc..

Who makes Oral [14C]PF-07220060?

Oral [14C]PF-07220060 is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).

What is the generic name of Oral [14C]PF-07220060?

oral-14c-pf-07220060 is the generic (nonproprietary) name of Oral [14C]PF-07220060.

What development phase is Oral [14C]PF-07220060 in?

Oral [14C]PF-07220060 is in Phase 1.

Manufacturer: Pfizer Inc. — full pipeline